By Sarah Pringle
Waud Capital Partners has joined forces with seasoned healthcare executive Paul Jardina in a pledge to find and build out a new platform in the medication-based services industry.
The Chicago mid-market firm will commit at least $100 million in equity capital to the company.
The new venture will seek to acquire and build an organization that either directly administers medication services or supports the commercialization or distribution of medications.
More specifically, the initiative will evaluate opportunities spanning medication-based physician practices, such as rheumatology, neurology, allergy/immunology, ear nose and throat and infectious disease; specialized pharmacies; alternative site infusion pharmacies; and pharmaceutical hub and distribution services.
To read more of this piece, go to the full article posted on PE Hub.